Antiverse raises £1.4m to bolster AI antibody drug discovery platform
Company is focused on identifying therapies for cancer, heart and lung diseases
Read More
Tag: seed funding
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
